Gelonghui April 30, Fu'an Pharmaceutical Industry (300194) (300194Goodgamepoker2(.SZ) announced that Qingyutang Pharmaceutical Co., Ltd. (Qingyutang), a wholly owned subsidiary of the company, recently received a drug registration certificate issued by the State Drug Administration (SDA). The related drugs are Pentazoxine injection and midazolam injection.
Pentazoxine injection is suitable for all kinds of chronic severe pain, such as cancer pain, traumatic pain and postoperative pain. It can also be given before operation or before anesthesia as an auxiliary drug for surgical anesthesia. Up to now, two enterprises (including Qingyutang) have passed the consistency evaluation or regarded as passing the consistency evaluation.
The indications of midazolam injection areGoodgamepoker21. Intramuscular or intravenous injection for preoperative sedation / anti-anxiety / amnesia. 2. Intravenous injection for diagnosis, treatment, endoscopic surgery (such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography, cardiac catheterization, tumor surgery, radiation process, suture laceration and other drugs used alone or in combination with other central nervous system inhibitors) sedation / anti-anxiety / memory loss before or during the operation. 3. Intravenous injection is used to induce general anesthesia before the administration of other anesthetics. In the case of anesthetic prophylaxis, anesthetic induction can be achieved in a relatively narrow dose range and in a short time. Intravenous midazolam can also be used as an intravenous supplement of nitrous oxide and oxygen (combined anesthesia). 4. Continuous intravenous infusion of midazolam as an anesthetic for sedation in patients with endotracheal intubation and mechanical ventilation, or in critically ill nursing treatment. Up to now, 4 enterprises (including Qingyutang) have passed the consistency evaluation or regarded as passing the consistency evaluation.